[Pharmacokinetics and antilipolytic effect of a derivative of nicotinic acid (sorbinicate) in dialyzed uremic patients].
作者信息
Zuliani U, Bonetti A, Orlandini G, Manari A, David S, Garini G
出版信息
Farmaco Prat. 1981 Sep;36(9):416-23.
PMID:7308427
Abstract
摘要
相似文献
1
2
3
Some aspects of sorbinicate pharmacokinetics.山梨醇缩苯甲醛的药代动力学的某些方面。
Arzneimittelforschung. 1980;30(8):1278-84.
4
5
[Effect of sorbinicate on blood proteins and platelet aggregation in patients with coronary disease].[山梨醇缩苯甲醛对冠心病患者血液蛋白质及血小板聚集的影响]
Clin Ter. 1984 Jul 31;110(2):111-8.
6
Comparative evaluation of some pharmacological properties and side effects of D-glucitol hexanicotinate (sorbinicate) and nicotinic acid correlated with the plasma concentration of nicotinic acid.D-葡萄糖醇己烟酸盐（山梨醇烟酸盐）和烟酸的某些药理特性及副作用与烟酸血药浓度的比较评估
Atherosclerosis. 1980 May;36(1):135-48. doi: 10.1016/0021-9150(80)90207-5.
7
[The use of sorbinicate in the treatment of hyperlipoproteinemia type IIa and IIb].
Farmaco Prat. 1981 Jan;36(1):13-22.
8
Effect of D-glucitol-hexanicotinate on platelet aggregability in patients with coronary heart disease.
Int J Clin Pharmacol Ther Toxicol. 1984 May;22(5):265-8.
9
Metabolic changes induced by a nicotinic acid derivative in patients with obesity grades 1, 2 and 3.一种烟酸衍生物在1级、2级和3级肥胖患者中引起的代谢变化。
Panminerva Med. 1979 Jul-Sep;21(3):111-26.
10
Effects of experimental atherosclerosis on cerebral blood flow in rabbits. Reversal by sorbinicate.
Artery. 1982;11(1):64-73.
Zotero 插件